Abstract: The present invention relates to compounds suitable for use in electronic devices, and to electronic devices, especially organic electroluminescent devices, comprising these compounds.
Abstract: The present invention relates to biomarkers associated with the clinical response to an FGF-18 compound before or during treatment of a cartilage disorder. It relates more particularly to specific proteins present in the blood, serum, synovial fluid or in the urine, which can be used as biomarkers for the diagnosis, pre-treatment of patients and during therapy of cartilage disorders. The invention can be used in predicting the response to an FGF-18 compound treatment, before starting the treatment or during the treatment. It could be used for selecting/identifying subjects to be treated according to specific doses and/or dosing regimens by intra-articular administration of an FGF-18 compound. The use of these biomarkers in diagnostics could result in increased benefit and reduced risk-benefit ratio in subjects.
Type:
Grant
Filed:
September 28, 2018
Date of Patent:
October 11, 2022
Assignee:
MERCK PATENT GMBH
Inventors:
Christoph H. Ladel, Hans Guehring, Anne-Christine Bay-Jensen, Morten Karsdal, Per Qvist
Abstract: [Problem] To provide a positive type photosensitive polysiloxane composition that can manufacture a cured film having a high surface smoothness, in which generation of wrinkles is suppressed even without adding a curing auxiliary or performing flood exposure. [Means for Solution] A positive type photosensitive polysiloxane composition comprising (I) a polysiloxane, (II) a carboxylic acid compound that is a monocarboxylic acid or a dicarboxylic acid, of 200 to 50,000 ppm based on the total mass of the composition, (III) a diazonaphthoquinone derivative, and (IV) a solvent, and a method for manufacturing a cured film using the composition.
Abstract: [Problem] To provide a novel polymer, which fills trenches having narrow widths and high aspect ratios and can form a thicker film. [Means for Solution] The block copolymer comprises a linear or cyclic block A having a polysilane skeleton comprising 5 or more silicon and a block B having a polysilazane skeleton comprising 20 or more silicon.
Abstract: The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
Type:
Grant
Filed:
August 26, 2019
Date of Patent:
October 11, 2022
Assignee:
MERCK PATENT GMBH
Inventors:
Rouven Linge, Sebastian Meyer, Lara-Isabel Rodriguez, Aaron Lackner
Abstract: Effect pigments based on Al2O3 flakes with high weather resistance and less photoactivity and to their use thereof in paints, industrial coatings, automotive coatings, printing inks, cosmetic formulations. The effect pigments have a ratio of the amount by weight of Al2O3 of the Al2O3 flake and the amount by weight of the metal oxide(s) of the coating layer(s) in the range of from 27:73 to 83:17 based on the total weight of the effect pigment.
Type:
Grant
Filed:
December 19, 2018
Date of Patent:
October 4, 2022
Assignee:
Merck Patent GmbH
Inventors:
Sabine Schoen, Michael Jungnitz, Stefan Schlueter, Kirsten Fritsche, Carsten Plueg, Stephanie Andes, Ulrich Schoenefeld
Abstract: A light valve that is operable in and electrically switchable between an optically clear and transparent state and an opaque state, wherein one or more polymerisable mesogenic compounds provided in a layer containing a liquid-crystalline medium that comprises one or more mesogenic compounds, one or more chiral compounds, one or more dichroic dyes and the one or more polymerisable mesogenic compounds are subjected to photopolymerisation. Further, a liquid-crystalline medium used in the method, a light valve obtained or respectively obtainable by carrying out the method, and the use of the light valve in mobile devices.
Type:
Application
Filed:
June 15, 2020
Publication date:
September 29, 2022
Applicant:
Merck Patent GmbH
Inventors:
Christian Schoenefeld, Michael Junge, Mark Goebel, Raphael Lisicki, Kevin Kaiser
Abstract: The invention relates to benzimidazole derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
Type:
Application
Filed:
March 14, 2022
Publication date:
September 29, 2022
Applicant:
Merck Patent GmbH
Inventors:
Eva-Maria TANZER, Kai SCHIEMANN, Markus KLEIN
Abstract: The present invention relates to aromatic isothiocyanates of formula U as defined in claim 1, to liquid-crystalline media comprising one or more compounds of formula U and to high-frequency components comprising these media, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves, tunable filters, tunable metamaterial structures, and electronic beam steering antennas, e.g. phased array antennas.
Abstract: The invention relates to a liquid-crystalline medium and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PM-VA, SS-VA, PALC, IPS, PS-IPS, FFS or PS-FFS effect.
Abstract: The invention relates to benzimidazole derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
Type:
Grant
Filed:
August 20, 2018
Date of Patent:
September 27, 2022
Assignee:
Merck Patent GmbH
Inventors:
Eva-Maria Tanzer, Kai Schiemann, Markus Klein
Abstract: Effect pigments based on Al2O3 flakes with high weather resistance and less photoactivity and to their use thereof in paints, industrial coatings, automotive coatings, printing inks, cosmetic formulations. The effect pigments have a ratio of the amount by weight of Al2O3 of the Al2O3 flake and the amount by weight of the metal oxide(s) of the coating layer(s) in the range of from 27:73 to 83:17 based on the total weight of the effect pigment.
Type:
Grant
Filed:
February 22, 2017
Date of Patent:
September 27, 2022
Assignee:
Merck Patent GmbH
Inventors:
Sabine Schoen, Michael Jungnitz, Stefan Schlueter, Kirsten Fritsche, Carsten Plueg, Stephanie Andes, Ulrich Schoenefeld
Abstract: The present application relates to a blue light-emitting organic electroluminescent device (OLED) having an anode, a cathode, at least one blue light-emitting layer and at least one hole-transport layer, wherein the at least one blue light-emitting layer comprises an elongated bis-indenofluorene derivative as a main component and wherein the at least one hole-transport layer comprises a polymer with non-conjugated units as a main component as well as to a method for producing the organic electroluminescent device.
Type:
Grant
Filed:
June 29, 2018
Date of Patent:
September 27, 2022
Assignee:
MERCK PATENT GMBH
Inventors:
Katja Scheible, Beate Burkhart, Nils Koenen, Lara-Isabel Rodriguez, Sebastian Meyer, Rouven Linge, Miriam Engel, Aaron Lackner, Holger Heil
Abstract: The present invention relates to Bisbenzofuran-fused indeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLEDs).
Type:
Grant
Filed:
November 22, 2017
Date of Patent:
September 27, 2022
Assignee:
MERCK PATENT GMBH
Inventors:
Rouven Linge, Lara-Isabel Rodriguez, Sebastian Meyer, Holger Heil
Abstract: The present invention relates to liquid-crystalline (LC) media and to LC displays (LCDs) containing these media, in particular to LCDs of the twisted nematic (TN) mode, preferably to displays of the LCOS (LC on silicon) mode.
Type:
Application
Filed:
August 26, 2020
Publication date:
September 22, 2022
Applicant:
Merck Patent GmbH
Inventors:
Nicole (I-Yun) HUANG, Eason (Chi-Shun) HUANG, Ray (Kuang-Ting) CHOU
Abstract: The present invention relates to a composition comprising a specific bipolar host and a triphenylene derivative, to the use thereof in electronic devices and electronic devices comprising said composition.
Type:
Grant
Filed:
November 12, 2018
Date of Patent:
September 20, 2022
Assignee:
MERCK PATENT GMBH
Inventors:
Christian Eickhoff, Amir Parham, Jonas Kroeber, Tobias Grossmann, Anja Jatsch, Christian Ehrenreich
Abstract: The invention relates to spirobifluorene derivatives which are substituted with electron transport groups, in particular for use in electronic devices. The invention further relates to a method for producing the compounds according to the invention, and to electronic devices comprising the same.
Abstract: The invention relates to a liquid-crystalline medium, preferably having a nematic phase and dielectric anisotropy of 0.5 or more, which comprises one or more compounds of formula T in which and the other parameters have the meanings given in the text, to the use thereof in an electro-optical display, particularly in an active-matrix display based on the IPS or FFS effect, to displays of this type which contain a liquid-crystalline medium of this type, and to the compounds of formula T and their use for the improvement of the transmission and/or response times of a liquid-crystalline medium which comprises one or more additional mesogenic compounds.
Type:
Grant
Filed:
June 26, 2019
Date of Patent:
September 20, 2022
Assignee:
Merck Patent GmbH
Inventors:
Atsutaka Manabe, Constanze Brocke, Sven Baran, Sebastian Hofmeyer, Alexander Hahn
Abstract: A liquid-crystalline medium having a nematic phase containing one or more compounds of formula D the use thereof in an electro-optical display, particularly in an active-matrix display based on the IPS or FFS effect, displays of this type which contain a liquid-crystalline medium of this type and the use of the compounds of formula D for improvement of the contrast and/or response times of a liquid-crystalline medium which contain one or more additional mesogenic compounds, as well as certain compounds of formula D.
Type:
Grant
Filed:
December 18, 2020
Date of Patent:
September 20, 2022
Assignee:
Merck Patent GmbH
Inventors:
Sven Christian Laut, Martina Windhorst, Constanze Brocke